JP2022532075A5 - - Google Patents

Info

Publication number
JP2022532075A5
JP2022532075A5 JP2021565885A JP2021565885A JP2022532075A5 JP 2022532075 A5 JP2022532075 A5 JP 2022532075A5 JP 2021565885 A JP2021565885 A JP 2021565885A JP 2021565885 A JP2021565885 A JP 2021565885A JP 2022532075 A5 JP2022532075 A5 JP 2022532075A5
Authority
JP
Japan
Prior art keywords
glycero
approximately
peg
phosphocholine
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021565885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532075A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/032241 external-priority patent/WO2020227690A1/en
Publication of JP2022532075A publication Critical patent/JP2022532075A/ja
Publication of JP2022532075A5 publication Critical patent/JP2022532075A5/ja
Withdrawn legal-status Critical Current

Links

JP2021565885A 2019-05-08 2020-05-08 Vegf-aポリペプチドをコードする改変rnaを送達するために脂質ナノ粒子を使用する方法、及びこの脂質ナノ粒子を含む医薬組成物 Withdrawn JP2022532075A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962845184P 2019-05-08 2019-05-08
US62/845,184 2019-05-08
PCT/US2020/032241 WO2020227690A1 (en) 2019-05-08 2020-05-08 Methods of using lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide and pharmaceutical compositions comprising the same

Publications (2)

Publication Number Publication Date
JP2022532075A JP2022532075A (ja) 2022-07-13
JP2022532075A5 true JP2022532075A5 (cg-RX-API-DMAC7.html) 2023-05-10

Family

ID=71069932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021565885A Withdrawn JP2022532075A (ja) 2019-05-08 2020-05-08 Vegf-aポリペプチドをコードする改変rnaを送達するために脂質ナノ粒子を使用する方法、及びこの脂質ナノ粒子を含む医薬組成物

Country Status (5)

Country Link
US (1) US20220226243A1 (cg-RX-API-DMAC7.html)
EP (1) EP3965745A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022532075A (cg-RX-API-DMAC7.html)
CN (1) CN114173826A (cg-RX-API-DMAC7.html)
WO (1) WO2020227690A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114306279A (zh) * 2021-12-30 2022-04-12 复旦大学 基于科罗索酸或其类似物的脂质纳米颗粒系统及其制备方法和应用
CN114617980A (zh) * 2022-03-09 2022-06-14 广州国家实验室 可电离脂质纳米颗粒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3247398A4 (en) * 2015-01-23 2018-09-26 Moderna Therapeutics, Inc. Lipid nanoparticle compositions
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
WO2017194454A1 (en) * 2016-05-09 2017-11-16 Astrazeneca Ab Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof
PT3464338T (pt) * 2016-06-07 2021-10-19 Modernatx Inc Arn modificado que codifica polipéptidos vegf-a, formulações e respetivos usos
MA50522B1 (fr) * 2017-10-31 2022-09-30 Astrazeneca Ab 151 85 Soedertaelje Nanoparticules lipidiques pour l'administration d'un arn modifié codant pour un polypeptide vegf-a

Similar Documents

Publication Publication Date Title
IL274230B2 (en) Lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide
JP2021508434A5 (cg-RX-API-DMAC7.html)
TWI866908B (zh) 用於治療肺部疾病的可吸入的緩釋組成物
JP5355890B2 (ja) グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
CN107260679B (zh) 用以减少眼用类固醇的并发症的药物组合物
WO2016036735A1 (en) Liposome-based mucus-penetrating particles for mucosal delivery
CN118766874B (zh) 一种吸入式制剂、迭代优化流程及其应用
JPWO2013176223A1 (ja) 炎症性疾患治療用医薬組成物
JP4874097B2 (ja) 水難溶性カンプトテシン含有リポソーム製剤
US20250177483A1 (en) Transmembrane stem cell factor (tm-scf) lipid nanocarriers and methods of use thereof
EP3496704B1 (en) Liposomal composition containing mild acidic active agent
JP2022532075A (ja) Vegf-aポリペプチドをコードする改変rnaを送達するために脂質ナノ粒子を使用する方法、及びこの脂質ナノ粒子を含む医薬組成物
JP2025506429A5 (cg-RX-API-DMAC7.html)
US12514820B2 (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
TW202519194A (zh) 用於疼痛控制之關節內皮質類固醇的微脂體組成物
NZ820531A (en) Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof
KR20250172196A (ko) 폐 계면활성제 및 항섬유화제를 포함하는 폐섬유증의 예방 또는 치료용 조성물 및 이의 제조방법
Pylypenko “QUALITY BY DESIGN” IN LIPOSOMAL DRUGS CREATION
TW202415382A (zh) 脂質體藥物組合物及其製備方法和用途
HK1242192A1 (en) Pharmaceutical compositions to reduce complications of ocular steroid
HK1201723B (en) Pharmaceutical compositions to reduce complications of ocular steroid